1. Home
  2. VIGL vs BAER Comparison

VIGL vs BAER Comparison

Compare VIGL & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • BAER
  • Stock Information
  • Founded
  • VIGL 2020
  • BAER 2014
  • Country
  • VIGL United States
  • BAER United States
  • Employees
  • VIGL N/A
  • BAER N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • BAER Blank Checks
  • Sector
  • VIGL Health Care
  • BAER Finance
  • Exchange
  • VIGL Nasdaq
  • BAER Nasdaq
  • Market Cap
  • VIGL 125.3M
  • BAER 115.9M
  • IPO Year
  • VIGL 2022
  • BAER N/A
  • Fundamental
  • Price
  • VIGL $3.40
  • BAER $2.02
  • Analyst Decision
  • VIGL Buy
  • BAER Strong Buy
  • Analyst Count
  • VIGL 5
  • BAER 1
  • Target Price
  • VIGL $16.60
  • BAER $5.25
  • AVG Volume (30 Days)
  • VIGL 92.9K
  • BAER 172.0K
  • Earning Date
  • VIGL 11-05-2024
  • BAER 11-11-2024
  • Dividend Yield
  • VIGL N/A
  • BAER N/A
  • EPS Growth
  • VIGL N/A
  • BAER N/A
  • EPS
  • VIGL N/A
  • BAER N/A
  • Revenue
  • VIGL N/A
  • BAER $73,248,000.00
  • Revenue This Year
  • VIGL N/A
  • BAER $26.61
  • Revenue Next Year
  • VIGL N/A
  • BAER N/A
  • P/E Ratio
  • VIGL N/A
  • BAER N/A
  • Revenue Growth
  • VIGL N/A
  • BAER 60.82
  • 52 Week Low
  • VIGL $2.47
  • BAER $1.71
  • 52 Week High
  • VIGL $9.24
  • BAER $8.78
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 48.43
  • BAER 36.43
  • Support Level
  • VIGL $3.20
  • BAER $2.26
  • Resistance Level
  • VIGL $3.48
  • BAER $2.82
  • Average True Range (ATR)
  • VIGL 0.20
  • BAER 0.27
  • MACD
  • VIGL 0.01
  • BAER -0.02
  • Stochastic Oscillator
  • VIGL 41.10
  • BAER 1.03

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF ("Super Scooper") aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: